Genitourinary Syndrome: Difference between revisions
No edit summary |
No edit summary |
||
Line 23: | Line 23: | ||
== Diagnostic Procedures == | == Diagnostic Procedures == | ||
== Outcome Measures == | |||
== Outcome Measures | |||
[https://cdn-links.lww.com/permalink/meno/a/meno_2012_12_11_erekson_201648_sdc1.pdf Vulvovaginal Symptoms Questionnaire.] | [https://cdn-links.lww.com/permalink/meno/a/meno_2012_12_11_erekson_201648_sdc1.pdf Vulvovaginal Symptoms Questionnaire.] | ||
Line 35: | Line 29: | ||
[https://www.ashasexualhealth.org/pdfs/DIVA.pdf Day-to-Day Impact of Vaginal Aging (DIVA) Questionnaire]<ref>Huang AJ, Gregorich SE, Kuppermann M, Nakagawa S, Van Den Eeden SK, Brown JS, Richter HE, Walter LC, Thom D, Stewart AL. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280352/#:~:text=The%20Day%2Dto%2DDay%20Impact%20of%20Vaginal%20Aging%20(DIVA,postmenopausal%20women%20of%20diverse%20backgrounds. The day-to-day impact of vaginal aging questionnaire: A multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women]. Menopause (New York, NY). 2015 Feb;22(2):144.</ref>[https://www.ashasexualhealth.org/pdfs/DIVA.pdf .] | [https://www.ashasexualhealth.org/pdfs/DIVA.pdf Day-to-Day Impact of Vaginal Aging (DIVA) Questionnaire]<ref>Huang AJ, Gregorich SE, Kuppermann M, Nakagawa S, Van Den Eeden SK, Brown JS, Richter HE, Walter LC, Thom D, Stewart AL. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280352/#:~:text=The%20Day%2Dto%2DDay%20Impact%20of%20Vaginal%20Aging%20(DIVA,postmenopausal%20women%20of%20diverse%20backgrounds. The day-to-day impact of vaginal aging questionnaire: A multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women]. Menopause (New York, NY). 2015 Feb;22(2):144.</ref>[https://www.ashasexualhealth.org/pdfs/DIVA.pdf .] | ||
== Management / Interventions | == Management / Interventions == | ||
add text here relating to management approaches to the condition<br> | add text here relating to management approaches to the condition<br> | ||
== Differential Diagnosis | == Differential Diagnosis == | ||
Dermatological conditions related to vulva; vaginitis, lichen sclerosus, chronic vulvovaginitis, or eczema. | |||
Vulvodynia | |||
Chronic pelvic pain | |||
== Resources <br> == | == Resources <br> == | ||
Revision as of 00:18, 20 October 2022
Top Contributors - Khloud Shreif, Temitope Olowoyeye and Lucinda hampton
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work!
Introduction[edit | edit source]
Genitourinary syndrome it was first introduced in 2014 it is a chronic condition affect women after menopause. GSM or as known previously a vulvovaginal atrophy, atrophic vaginitis, or urogenital atrophy.
It is a chronic progressive conditions that describe the changes result from the decereas in estrogen level after menopause on vulvovaginal and lower urinary tract.
the majority may be affected after menopause but about 15%of women may have symptoms premenopause . and may women consider it a normal process with aging process and they could not seek help so it remains underdiagnosed.
They do not consider it a condition need help. So they need medical awareness of their conditions[1].
Mechanism of Injury / Pathological Process
[edit | edit source]
add text here relating to the mechanism of injury and/or pathology of the condition
Clinical Presentation[edit | edit source]
add text here relating to the clinical presentation of the condition
Diagnostic Procedures[edit | edit source]
Outcome Measures[edit | edit source]
Vulvovaginal Symptoms Questionnaire.
Day-to-Day Impact of Vaginal Aging (DIVA) Questionnaire[2].
Management / Interventions[edit | edit source]
add text here relating to management approaches to the condition
Differential Diagnosis[edit | edit source]
Dermatological conditions related to vulva; vaginitis, lichen sclerosus, chronic vulvovaginitis, or eczema.
Vulvodynia
Chronic pelvic pain
Resources
[edit | edit source]
add appropriate resources here
References[edit | edit source]
- ↑ Angelou K, Grigoriadis T, Diakosavvas M, Zacharakis D, Athanasiou S. The genitourinary syndrome of menopause: an overview of the recent data. Cureus. 2020 Apr 8;12(4).
- ↑ Huang AJ, Gregorich SE, Kuppermann M, Nakagawa S, Van Den Eeden SK, Brown JS, Richter HE, Walter LC, Thom D, Stewart AL. The day-to-day impact of vaginal aging questionnaire: A multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women. Menopause (New York, NY). 2015 Feb;22(2):144.